NanoViricides Inc. (NNVC)

[Trendliner]

SUPPORT AT 1.50 TO 1.60 APPEARS TO BE FAILING

The near-term target (prior to May 15) would be for a drop to 1.30 -1.35 but longer-term downside targets are well below 1.00. Worst case appears to be 50 cents, which can be justified as the price of a long-term call option on the stock. I ran the numbers using Black-Sholes, with critical assumptions made on volatility, and an expected option life based on cash-reserves and the increased burn-rate. At 50 cents it's a reasonable play on the possibility that they will pull off Herpecide for ocular infections.

I believe Dr. Vivian Boniuk, will be going or has already gone full-time with NNVC. With Dr. Boniuk at the controls, if Herpicide can happen she will make it happen. Then it's a minimum 10 dollar stock.... maybe 20, just based on Herpicide alone.

My biggest fundamental issue is the two classes to stock. I think it's unfair. But I'm a technician not a fundamentalist and I will leave that to the F-Analysts.

Joke: A fundamentalist and a technician go to lunch to find some common ground. During lunch the technician accidentally knocks a steak knife off the table and it goes into the foot of the fundamentalist. He screams in pain and asks why the technician did nothing to help him. The technician's retort - " I don't try to catch falling knives". Technician asks - "What didn't you move your foot?"

Fundamentalist: " I didn't think it would go that low"